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The Role of Hfe in Transferrin-Bound Iron Uptake by
Hepatocytes
Anita C.G. Chua,1 Carly E. Herbison,1 Sarah F. Drake,1 Ross M. Graham,1 John K. Olynyk,1,2 and Debbie Trinder1,2
HFE-related hereditary hemochromatosis results in hepatic iron overload. Hepatocytes ac-
quire transferrin-bound iron via transferrin receptor (Tfr) 1 and Tfr1-independent pathways
(possibly Tfr2-mediated). In this study, the role of Hfe in the regulation of hepatic trans-
ferrin-bound iron uptake by these pathways was investigated usingHfe knockout mice. Iron
and transferrin uptake by hepatocytes fromHfe knockout, non–iron-loaded and iron-loaded
wild-type mice were measured after incubation with 50 nM 125I-Tf-59Fe (Tfr1 pathway) and
5 M 125I-Tf-59Fe (Tfr1-independent or putative Tfr2 pathway). Tfr1 and Tfr2 messenger
RNA (mRNA) and protein expression were measured by real-time polymerase chain reaction
and western blotting, respectively. Tfr1-mediated iron and transferrin uptake byHfe knock-
out hepatocytes were increased by 40% to 70% compared with iron-loaded wild-type hepa-
tocytes with similar iron levels and Tfr1 expression. Iron and transferrin uptake by the
Tfr1-independent pathway was approximately 100-fold greater than by the Tfr1 pathway
and was not affected by the absence of Hfe. Diferric transferrin increased hepatocyte Tfr2
protein expression, resulting in a small increase in transferrin but not iron uptake by the
Tfr1-independent pathway. Conclusion: Tfr1-mediated iron uptake is regulated by Hfe in
hepatocytes. The Tfr1-independent pathway exhibited a much greater capacity for iron
uptake than the Tfr1 pathway but it was not regulated by Hfe. Diferric transferrin up-
regulated hepatocyte Tfr2 protein expression but not iron uptake, suggesting that Tfr2 may
have a limited role in the Tfr1-independent pathway. (HEPATOLOGY 2008;47:1737-1744.)
Ahomozygous C282Y mutation in the HFE generesults in hereditary hemochromatosis and is char-acterized by increased iron absorption and trans-
ferrin saturation that leads to hepatic iron overload. The
hemochromatosis protein, HFE, is closely associated with
transferrin receptor 1 (TFR1) and competes with trans-
ferrin for the same binding sites on TFR1.1 Hepatocytes
acquire transferrin-bound iron via TFR1 by a high-afﬁn-
ity endocytic process.2 A second transferrin receptor has
been identiﬁed and was named transferrin receptor 2
(TFR2). Like TFR1, it transports transferrin-bound iron
by a receptor-mediated endocytic process,3 although the
afﬁnity of this pathway is up to 30-fold lower than that of
TFR1.4 In iron overload, transferrin saturation and difer-
ric transferrin levels are increased, resulting in an up-reg-
ulation of TFR2 protein expression,5,6 suggesting that
hepatocyte iron loading may involve TFR2. It has been
postulated that TFR2 may mediate the TFR1-indepen-
dent uptake process described previously in hepatic
cells.7-9
In addition to its role in iron transport, TFR2 also has
a role in the regulation of cellular iron metabolism be-
cause mutations in TFR2 cause hepatic iron overload.10,11
TFR2 is predominantly expressed in hepatocytes12 and
has recently been shown to interact with HFE.13 Unlike
TFR1, TFR2 is not regulated by intracellular iron levels
because there are no iron-responsive elements in the un-
translated region of its messenger RNA (mRNA).12
Hepcidin is synthesized by hepatocytes and is a key
regulator of iron homeostasis.14 It has been proposed that
the binding of diferric transferrin to the TFR1–HFE
complex and TFR2 regulates hepcidin synthesis.15 The
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loss of functional TFR2 or HFE in humans and mice
results in low hepcidin levels.16-20 Furthermore, TFR2
and HFE are highly expressed by hepatocytes,12,21 sup-
porting a role for these proteins in the regulation of hep-
cidin synthesis.
In the current study, the role of Hfe in transferrin-
bound iron uptake by hepatocytes was evaluated in the
Hfe knockout mouse. Results indicated that Tfr1 expres-
sion and Tfr1-mediated transferrin-bound iron uptake by
hepatocytes are regulated by Hfe. However, whereas Tfr2
protein expression is regulated by Hfe, transferrin-bound
iron uptake mediated by the Tfr1-independent pathway
is not, suggesting that Tfr2 has a limited role in hepato-
cyte iron transport mediated by the Tfr1-independent
pathway.
Materials and Methods
Animals. Hfe knockout and wild-type mice on a
C57BL/6 background (Animal Resource Centre, Mur-
doch, Australia) were fed a normal rodent chow contain-
ing control iron levels (0.007%) ad libitum. Another
group of wild-type mice were fed an iron-supplemented
diet [2% carbonyl iron (Sigma, St Louis, MO)] for 3
weeks to iron load hepatocytes in vivo.22
Primary Hepatocyte Culture. Mouse hepatocytes
were isolated and cultured from livers of 11-week-old fe-
male Hfe knockout and non–iron-loaded wild-type mice
as described previously.23 Hepatocytes were also isolated
from iron-loaded wild-type mice to obtain cells with sim-
ilar iron levels to the Hfe knockout hepatocytes to control
for the effects of iron loading. This study was approved by
the Animal Ethics Committee of The University ofWest-
ern Australia and is in accordance with the guidelines set
in the Guide for the Care and Use of Laboratory Animals
prepared by the US National Academy of Sciences.
Radiolabeling of Transferrin. Human apotrans-
ferrin (Sigma) was radiolabeled with 59Fe and 125I
(PerkinElmer, Melbourne, Australia) as described previ-
ously.24,25 Brieﬂy, apotransferrin was saturated with iron,
using 59FeCl3 and 56FeSO4,mixedwith a 10-fold excess of
nitrilotriacetic acid. The resulting diferric transferrin was
labeled with 125I using iodine monochloride, after which
the labeled transferrin (59Fe-125I-Tf) was eluted through a
PD-10 desalting column (GE Healthcare Life Sciences,
Rydalmere, Australia) to remove free 125I and nitrilotri-
acetic acid. Typically, less than 1% of free 125I was de-
tected in the protein solution, and the speciﬁc activity of
59Fe-125I-Tf was 250 to 300 cpm/pmol 59Fe and 6,000 to
8,000 cpm/pmol 125I.
Transferrin-Bound Iron Uptake by Hepatocytes.
The effects of increasing concentrations of 59Fe-125I-Tf (1
nM to 25 M transferrin) on iron uptake and transferrin
binding by Hfe knockout and non–iron-loaded wild-type
hepatocytes were examined. In these experiments, hepa-
tocytes were washed 3 times with Hanks’ buffer (Trace
Biosciences Pty. Ltd., Sydney, Australia) and the cells in-
cubated with 59Fe-125I-Tf in Dulbecco’s modiﬁed Eagle’s
medium (Invitrogen, Melbourne, VIC, Australia) con-
taining 2% bovine serum albumin (Trace Biosciences),
pH 7.4, for 2 hours at 37°C. Iron uptake was performed
at 37°C, and transferrin binding performed at 4°C. At the
end of the incubation period, hepatocytes were washed 5
times with coldHanks’ buffer and the cells lysed in a 0.1%
Triton X-100 (BDH AnalaR, Kilsyth, Australia) and 0.1
M sodiumhydroxide solution and collected into counting
tubes. The radioactivity in the hepatocytes was measured
in a gamma-counter (Wallac, Turku, Finland), and iron
uptake and transferrin binding were expressed as nmol/g
protein to adjust for variation in cell density. The amount
of protein in the cells was determined using bicinchoninic
acid (Pierce, Rockford, IL). The maximal rate of Tfr1-
mediated iron uptake and transferrin binding was deter-
mined in the concentration range of 1 to 50 nM
transferrin, whereas that mediated by the Tfr1-indepen-
dent pathway was estimated in the concentration range of
0.1 to 25 M transferrin using least squares curve ﬁtting
to theMichaelis-Menten andHill equations, respectively.
Nonspeciﬁc iron uptake mediated by the Tfr1 pathway
was determined by extrapolating from the slope of the
linear section of the curve at high 59Fe-125I-Tf concentra-
tions and speciﬁc Tfr1-mediated iron uptake determined
by subtracting nonspeciﬁc uptake from total iron uptake.
In the kinetics study, Hfe knockout, non–iron-loaded,
and iron-loaded wild-type hepatocytes were incubated
with 59Fe-125I-Tf (50 nM or 5 M transferrin) in Dul-
becco’s modiﬁed Eagle’s medium containing 2% bovine
serum albumin for 0 to 2 hours at 37°C to measure the
rate of transferrin-bound iron uptake. The concentrations
are standard concentrations used to analyze Tfr1 and
Tfr1-independent (putative Tfr2) pathways, respective-
ly.26 The effect of diferric transferrin treatment on iron
and transferrin uptake was also investigated. Hepatocytes
were treated with 5 or 15 M diferric transferrin in 10%
fetal bovine serum-supplemented medium for 24 hours.
After treatment with diferric transferrin, hepatocytes were
incubated with 59Fe-125I-Tf (5 M transferrin) in Dul-
becco’s modiﬁed Eagle’s medium containing 2% bovine
serum albumin for 1 hour at 37°C.
RNA Expression. Total RNA was isolated from cul-
tured hepatocytes using RNA-wiz (Ambion, Austin, TX),
treated with deoxyribonuclease I (Ambion) and reverse
transcribed using SuperScript II reverse transcriptase (In-
vitrogen). Quantiﬁcation of mouse Tfr1, Tfr2, hepcidin,
1738 CHUA ET AL. HEPATOLOGY, May 2008
and -actin mRNA transcripts were measured by real-
time polymerase chain reaction in a Rotorgene (Corbett
Research, NSW, Australia) using Tfr1 (NM_011638)
forward (5-TTCCTACATCATCTCGCTTAT-3) and
reverse (5-CATAGTGTTCATCTCGCCAGA-3) prim-
ers, Tfr2 (NM_015799) forward (5-CCGCTATGGA-
GACGTGGTT-3) and reverse (5-TGGCGACACAT-
ACTGGGGACAG-3) primers, hepcidin (NM_032541)
forward (5-CCTATCTCCATCAACAGATG-3) and
reverse (5-AACAGATACCACACTGGGAA-3) prim-
ers and -actin (NM_007393) forward (5-CTGGCAC-
CACACCTTCTA-3) and reverse (5-GGGCACAG-
TGTGGGTGAC-3) primers, respectively. Tfr1, Tfr2,
and hepcidin mRNA expression were normalized against
-actin mRNA expression.
Western Blotting. Hepatocyte protein samples were
prepared as previously described.23 Protein samples (60
g) were heated at 85°C for 10 minutes in Laemmli
buffer and separated by 8% sodium dodecyl sulfate poly-
acrylamide gel electrophoresis. The proteins were electro-
blotted onto polyvinylidene ﬂuoride membranes
(Millipore, North Ryde, Australia). Hepatocyte Tfr1 and
Tfr2 protein expression was detected using mouse anti-
human Tfr1 (Zymed Laboratories; Invitrogen) and rabbit
anti-mouse Tfr2 (Alpha Diagnostic International, San
Antonio, TX) antibodies, respectively. The membranes
were reprobed for detection of actin (goat anti-mouse
antibody; Santa Cruz Biotechnology, Santa Cruz, CA).
Expression of Tfr1 and Tfr2 were normalized against ac-
tin expression.
Statistical Analysis. Results are expressed as dupli-
cate measurements or the mean  standard error of the
mean (SEM) of triplicate values within each experiment,
unless stated otherwise. Each experiment was performed
at least 3 times. Statistically signiﬁcant differences be-
tween groups were determined using Student unpaired t
test at the 95% conﬁdence level.
Results
Effect of Transferrin Concentration on Iron Up-
take and Transferrin Binding. As the extracellular con-
centration of 59Fe-125I-Tf was increased from 1 to 50 nM
transferrin at 37°C, the speciﬁc uptake of iron by hepato-
cytes from Hfe knockout and non–iron-loaded wild-type
mice reached saturation (Fig. 1A), indicating that iron
uptake was mediated by a receptor-mediated pathway.
The maximal velocity of uptake and the Michaelis-Men-
ten constant for iron uptake were estimated using the
software program, GraphPad Prism (Graphpad Software
Inc., San Diego, CA), using the Michaelis-Menten equa-
tion. Hepatocytes from Hfe knockout and non–iron-
loaded wild-type mice displayed similar maximal velocity
of uptake and Michaelis-Menten constant values (Table
1). Speciﬁc binding of transferrin to Hfe knockout and
non–iron-loaded wild-type hepatocytes was determined
at 4°C (Fig. 1B).Maximal transferrin binding and afﬁnity
constant for speciﬁc transferrin binding were estimated
usingGraphPad Prism using theHill equation. There was
no difference in transferrin binding (maximal transferrin
binding and afﬁnity constant) by Hfe knockout and non–
iron-loaded wild-type hepatocytes (Table 1). We have
previously shown that iron-loaded hepatocytes had lower
maximal velocity of uptake andmaximal transferrin bind-
ing values compared with non–iron-loaded hepatocytes,
Fig. 1. The effects of increasing extracellular diferric transferrin con-
centration on iron uptake and transferrin binding by hepatocytes. Hepa-
tocytes from Hfe knockout (black square) and non–iron-loaded wild-type
(white square) mice were incubated with 59Fe-125I-Tf for 2 hours. Iron
uptake (A, C) and transferrin binding (B, D) mediated by Tfr1 (1-50 nM
transferrin; A, B) and Tfr1-independent (0.1-25 M transferrin; C, D)
pathways were determined in the hepatocytes. Iron uptake and trans-
ferrin binding were performed at 37°C and 4°C, respectively. Results are
expressed as duplicate measurements (A-D). Graphs are representative
of 6 independent experiments performed.
Table 1. Maximum Rate of Iron Uptake (Vmax) and Maximum
Transferrin Binding (Bmax) by the Tfr1-Mediated Pathway in
Hepatocytes
Hfe Knockout
Non–Iron-Loaded
Wild-Type
Vmax (nmol iron/g protein/
2 hours) 0.99 0.17 0.92 0.13
Km (nM) 24 4 21 3
Bmax (pmol transferrin/g
protein) 41 3 41 4
K a (10–9/M) 0.11 0.01 0.10 0.02
Results are expressed as mean  SEM, n  6.
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whereas there was no difference in Michaelis-Menten
constant and afﬁnity constant.27
To investigate the Tfr1-independent pathway, Hfe
knockout and non–iron-loaded wild-type hepatocytes
were incubated with increasing concentrations of 59Fe-
125I-Tf from 0.1 to 25 M transferrin. Under these con-
ditions, iron uptake and transferrin binding by the
hepatocytes were not saturable (Fig. 1C,D) and were sim-
ilar in both Hfe knockout and non–iron-loaded wild-type
hepatocytes.
Kinetics of Transferrin-Bound Iron Uptake. Ki-
netic experiments were performed using hepatocytes from
Hfe knockout, non–iron-loaded, and iron-loaded wild-
type mice. Previously, we have shown that ferritin protein
levels in Hfe knockout and iron-loaded wild-type hepato-
cytes were similar, indicating that hepatic iron concentra-
tions were similar, and increased 6-fold compared with
non–iron-loaded wild-type hepatocytes.22 In this study,
the hepatocytes were incubated with either 50 nM trans-
ferrin (Tfr1 pathway) or 5m transferrin (Tfr1-indepen-
dent pathway) at 37°C. Iron uptake by hepatocytes was
linear over 2 hours (Fig. 2A, C), whereas transferrin up-
take reached a steady-state by approximately 1 hour (Fig.
2B, D). The uptake of transferrin-bound iron mediated
by the Tfr1-independent pathway was approximately 75-
fold to 100-fold greater than uptake by the Tfr1 pathway.
At 50 nM transferrin, there was no difference in iron
uptake by Hfe knockout and non–iron-loaded wild-type
hepatocytes. However, when uptake by Hfe knockout
hepatocytes was compared with uptake by iron-loaded
wild-type hepatocytes, the rate of iron uptake was in-
creased by approximately 70% (Fig. 2A; Table 2;P 
0.01). Likewise, transferrin uptake by Hfe knockout and
non–iron-loaded wild-type hepatocytes was similar, but
transferrin uptake by Hfe knockout hepatocytes was in-
creased by 40% compared with iron-loaded wild-type
hepatocytes (Fig. 2B; P 0.025). In contrast, the rate of
iron uptake from 5 M transferrin was similar in hepato-
cytes from all 3 mouse types (Fig. 2C; Table 2). Similarly,
there was no difference in transferrin uptake mediated by
the Tfr1-independent pathway (Fig. 2D).
Expression of Tfr1, Tfr2, and Hepcidin by Hepa-
tocytes. The expression of Tfr1, Tfr2, and hepcidin
mRNA and Tfr1 and Tfr2 protein by hepatocytes were
determined. Tfr1 mRNA expression was signiﬁcantly de-
creased by approximately 50% in both Hfe knockout and
iron-loaded wild-type hepatocytes compared with non–
iron-loaded wild-type cells (Fig. 3A; P  0.0001). Simi-
larly, Tfr1 protein expression was decreased by
approximately 70% in the Hfe knockout and iron-loaded
wild-type hepatocytes (Fig. 3B). In contrast, Tfr2 mRNA
expression was similar in the hepatocytes (Fig. 3A),
whereas Tfr2 protein expression was increased by 70% to
80% in the Hfe knockout and iron-loaded wild-type
hepatocytes compared with non–iron-loaded wild-type
cells (Fig. 3B).Tfr2mRNA and protein expression byHfe
knockout and iron-loaded wild-type hepatocytes were
similar. Hepcidin mRNA expression by Hfe knockout
hepatocytes was similar to non–iron-loaded wild-type
hepatocytes but decreased by 30% compared with iron-
loaded wild-type hepatocytes (Fig. 3A; P 0.025). Hep-
cidin mRNA expression by iron-loaded wild-type
hepatocytes was increased by 40% compared with non–
iron-loaded wild-type cells (Fig. 3A; P 0.025). Similar
patterns of expression in liver hepcidin were observed
(data not shown).
Table 2. Rate of Transferrin-Bound Iron Uptake by
Hepatocytes
Hfe
Knockout
Non–Iron-
Loaded
Wild-Type
Iron-
Loaded
Wild-Type
(pmol iron/g protein/minute)
Tfr1 pathway 5.5 0.3* 5.2 0.5 3.4 0.3**
Tfr1-independent pathway 425 24 440 28 480 44
Results are expressed as mean  SEM, n  3.
*P  0.01 Hfe knockout compared with iron-loaded wild-type hepatocytes.
**P  0.01 iron-loaded wild-type compared with non–iron-loaded wild-type
hepatocytes.
Fig. 2. Kinetics of iron and transferrin uptake by hepatocytes. Hepa-
tocytes from Hfe knockout (black squares), non–iron-loaded wild-type
(white squares), and iron loaded wild-type (black circles) mice were
incubated with 59Fe-125I-Tf for 0 to 2 hours at 37°C. The rate of iron (A,
C) and transferrin (B, D) uptake mediated by Tfr1 (50 nM transferrin; A,
B) and Tfr1-independent (5 M transferrin; C, D) pathways were deter-
mined in the hepatocytes. Results are expressed as duplicate measure-
ments (A, B) or mean  SEM, n  3 (C, D). Graphs are representative
of 3 independent experiments performed.
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Effects of Diferric Transferrin on Tfr2 Expression
and Transferrin-Bound Iron Uptake. Tfr2 protein ex-
pression by hepatoma cells has been shown to be up-
regulated by diferric transferrin.5,6 When Hfe knockout,
non–iron-loaded, and iron-loaded wild-type hepatocytes
were cultured in the presence of 5 or 15 M diferric
transferrin for 24 hours, Tfr2 protein expression was in-
creased (Fig. 4A). Iron uptake by the hepatocytes medi-
ated by the Tfr1-independent pathway was, however,
unchanged (Fig. 4B), although transferrin uptake was
slightly increased in the Hfe knockout and non–iron-
loaded wild-type hepatocytes (Fig. 4C; P  0.05).
Discussion
This study demonstrates unequivocally that Tfr1-me-
diated transferrin-bound iron uptake by hepatocytes is
regulated by Hfe. Despite similar Tfr1 mRNA and pro-
tein expression by Hfe knockout hepatocytes, both iron
and transferrin uptakemediated by Tfr1 were increased in
comparison with iron-loaded wild-type hepatocytes. The
lack of correlation between iron and transferrin uptake
and Tfr1 expression may be due to the absence of Hfe
competing with transferrin for Tfr1 binding and high-
lights the role of Hfe in the regulation of transferrin-
bound iron uptake by Tfr1 in hepatocytes. When
hepatocytes were treated with diferric transferrin, Tfr2
protein expression was up-regulated but iron uptake by
the Tfr1-independent pathway was unchanged. Further-
more, the Tfr1-independent pathway exhibited an ap-
proximately 100-fold greater capacity for iron uptake in
comparison with the Tfr1 pathway. This indicates that
not only is Tfr2 regulated in a different manner from
Tfr1, but the principal mechanism of iron uptake by
hepatocytes in iron overload is likely to be mediated by
the Tfr1-independent pathway, whichmay involvemech-
anisms other than that mediated by Tfr2.
It is well established that hepatic cells take up trans-
ferrin-bound iron by Tfr1-mediated endocytosis7,28,29
which is regulated by cellular iron levels.27 In this study,
Tfr1 mRNA and protein expression by Hfe knockout and
iron-loaded wild-type hepatocytes were down-regulated
compared with non–iron-loaded wild-type hepatocytes,
consistent with the iron-dependent regulation of Tfr1 by
the iron-responsive element iron regulatory protein post-
transcriptional mechanism.30 Decreased liver Tfr1
mRNA expression has been observed in Hfe knockout
mice31 whereas liver Tfr1 protein expression is undetect-
able in HFE-related hereditary hemochromatosis sub-
Fig. 3. Expression of Tfr1, Tfr2, and hepcidin by hepatocytes. Messenger RNA and protein expression were measured by real-time polymerase chain
reaction and western blotting, respectively. (A) Tfr1, Tfr2, and hepcidin mRNA were measured in Hfe knockout (Hfe KO), non–iron-loaded wild-type
(WT), and iron-loaded wild-type (Fe  WT) hepatocytes. Results are expressed as mean  SEM, n  6-14. @P  0.0001 and *P  0.025 Hfe
KO or Fe  WT compared with WT hepatocytes; #P  0.025 Hfe KO compared with Fe  WT hepatocytes. (B) Tfr1 and Tfr2 protein expression were
determined in Hfe knockout (Hfe KO), non–iron-loaded wild-type (WT), and iron-loaded wild-type (Fe  WT) hepatocytes. Results are expressed as
the mean of duplicate measurements. A representative blot of Tfr1 and Tfr2 protein expression from 3 independent experiments is shown. *P 0.025
Hfe KO or Fe  WT compared with WT hepatocytes.
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jects.32 The decrease in Tfr1 expression was, however, not
accompanied by a decrease in transferrin-bound iron up-
take nor transferrin binding in Hfe knockout hepatocytes
(Figs. 1, 2). This may be because in Hfe knockout hepa-
tocytes, the absence of competitive binding between Hfe
and transferrin to Tfr1 resulted in increased transferrin-
bound iron uptake despite the down-regulation of Tfr1,
whereas in wild-type hepatocytes, Hfe competed with
transferrin for binding to Tfr1 and decreased iron uptake.
Consequently, iron uptake by Hfe knockout hepatocytes
were similar to uptake by non–iron-loaded wild-type
hepatocytes but were increased compared with uptake by
iron-loadedwild-type hepatocytes (Fig. 2A). These results
demonstrate that Hfe is essential for the regulation of
Tfr1-mediated iron uptake from transferrin in hepato-
cytes. The regulation of iron uptake from transferrin by
HFE has also been demonstrated in Chinese hamster
ovary and HeLa cells overexpressing HFE.33,34
A low-afﬁnity Tfr1-independent uptake mechanism
for transferrin-bound iron has been well characterized in
hepatocytes and other cell types, including hepatoma and
melanoma cells.9,29,35-38 Cellular iron uptake from trans-
ferrin by the Tfr1-independent process is apparent after
the saturation of TFR1 and is quantitatively greater than
the Tfr1 pathway, as was evident in the current study.
This low-afﬁnity process is probably the more relevant
pathway of transferrin-bound iron uptake at physiological
concentrations of diferric transferrin. Because TFR2 is
highly expressed by hepatocytes and mediates transferrin-
bound iron uptake in overexpressing Chinese hamster
ovary and HeLa cells,3,8,12 it led to the hypothesis that
TFR2may be responsible for the Tfr1-independent path-
way in hepatocytes, although this has not been conﬁrmed.
Tfr2 protein regulation by diferric transferrin has been
reported in whole liver and hepatoma cells.5,6 In this
study, we extend these earlier observations by demonstrat-
ing a similar role in primary hepatocytes. Tfr2 protein
expression was increased in hepatocytes from Hfe knock-
out and iron-loaded wild-type mice compared with non–
iron-loaded mice (Fig. 3B). This is in agreement with the
Fig. 4. The effects of diferric transferrin on Tfr2 expression and iron and transferrin uptake by hepatocytes. Hepatocytes from Hfe knockout (left
panel), non–iron-loaded wild-type (middle panel), and iron-loaded wild-type (right panel) mice were cultured in the absence (control; 0 M) or
presence of 5 or 15 M diferric transferrin. Tfr2 protein expression (A) by hepatocytes was determined by western blotting. A representative blot of
Tfr2 protein expression from 3 independent experiments is shown. Iron (B) and transferrin (C) uptake by hepatocytes were measured after incubation
with 59Fe-125I-Tf (5 M transferrin) for 1 hour at 37°C. Results are expressed as mean SEM, n 3-5. Graphs are representative of 3 independent
experiments performed. *P  0.05 compared with control.
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posttranslational regulation of Tfr2 by diferric trans-
ferrin,6 which is increased in iron overload. Iron and
transferrin uptake mediated by the Tfr1-independent
pathway, however, were similar in Hfe knockout, non–
iron-loaded, and iron-loaded wild-type hepatocytes.
Likewise, when hepatocytes from the 3 mouse types were
cultured in the presence of exogenous diferric transferrin,
Tfr2 protein expression was up-regulated (Fig. 4A), con-
ﬁrming previous studies in hepatoma cells.5,6 The increase
in Tfr2 expression by hepatocytes was accompanied by a
small increase in transferrin uptake, but, surprisingly, it
was not associated with an increase in the rate of iron
uptake. These results suggest that Tfr2 may play a lesser
role in Tfr1-independent iron uptake than previously
thought. In support of this, we recently observed in hep-
atoma cells that changes in iron uptake were small when
Tfr2 protein expression was modiﬁed by diferric trans-
ferrin, Tfr2 overexpression, and Tfr2 underexpression us-
ing small interfering RNA.39 In addition, in vivo hepatic
iron uptake from plasma transferrin in Tfr2 (Y245X) mu-
tant mice with nonfunctional Tfr2 was only approxi-
mately 20% lower than in iron-loaded wild-type mice.40
This provides further support for a limited role of Tfr2 in
liver iron transport and suggests that other transferrin-
bound iron transport pathways exist. Tfr1-independent
transferrin-bound iron uptakemay occur by a low-afﬁnity
adsorptive process that involves the energy-dependent
and temperature-dependent endocytosis of transferrin
and pH-dependent release of iron.27,29,35,38 In addition,
incubation of hepatocytes with low-molecular-weight
iron complexes such as ferric ammonium citrate stimu-
lates transferrin-bound iron uptake by a Tfr1-indepen-
dent pathway41 and could be relevant in iron overload
disorders such as hereditary hemochromatosis, in which
plasma levels of non–transferrin-bound iron complexes
are increased.42
Mutations in the TFR2 gene result in hepatic iron
overload,10,11 indicating that TFR2 is important in the
regulation of iron homeostasis. The results from the cur-
rent study support the likelihood of TFR2 having a
greater role in the regulation of iron metabolism and a
lesser role in hepatic iron transport per se. It has been
proposed that TFR2 and HFE–TFR1 complex sense
plasma transferrin saturation and signal to hepatocytes to
modulate hepcidin synthesis. Recently, it was shown that
HFE also associates with TFR2.13 The mechanism by
which HFE, TFR1, and TFR2 sense iron is not yet com-
pletely understood.
Hepcidin expression is regulated by body iron levels
and is increased when iron concentration is high.14 Hep-
cidinmRNA expression byHfe knockout hepatocytes was
down-regulated compared with iron-loaded wild-type
hepatocytes and similar to non–iron-loaded hepatocytes.
These results are consistent with other studies that dem-
onstrated hepcidin mRNA expression was inappropri-
ately low in Hfe knockout mice despite hepatic iron
loading.16,17 In mice, hepcidin mRNA expression is af-
fected by the age and genetic background of the ani-
mals.16,17 Although Tfr1 expression by Hfe knockout
hepatocytes responded appropriately to increased hepatic
iron levels, the lack of regulation in Tfr1-mediated trans-
ferrin-bound iron uptake by Hfe knockout hepatocytes
suggests that the loss-of-function of Hfe may send an
erroneous signal to hepatocytes, leading to inappropriate
hepcidin synthesis. Similarly, the loss of functional Hfe
may result in aberrant iron sensing by Tfr2 in hepato-
cytes.
In conclusion, increased Tfr1-mediated iron and trans-
ferrin uptake by Hfe knockout compared with iron-
loaded wild-type hepatocytes despite a down-regulation
in Tfr1 mRNA and protein expression may be due to the
absence of Hfe competing with transferrin for binding to
Tfr1. These results demonstrated that Tfr1-mediated
transferrin-bound iron uptake was regulated by Hfe in
hepatocytes. The Tfr1-independent pathway exhibited a
greater capacity for iron uptake than the Tfr1 pathway,
but its regulation was not affected by the loss of functional
Hfe. Diferric transferrin up-regulated Tfr2 protein ex-
pression but not Tfr1-independent iron uptake, suggest-
ing that Tfr2 may not be the only transporter in this
pathway. The low levels of Tfr1 expression and the lim-
ited role of Tfr2 in transferrin-bound iron uptake by
hepatocytes suggest that Tfr1-mediated and Tfr2-medi-
ated iron uptake are unlikely to make a substantial con-
tribution to hepatocyte iron loading in the Hfe knockout
mouse; rather we propose that a pathway that is indepen-
dent of both Tfr1 and Tfr2 may contribute to in vivo
hepatic iron loading in the Hfe knockout mouse.
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